Phase III Randomized Trial of Patient-Specific Vaccination for Previously Untreated Patients with Follicular Lymphoma in First Complete Remission: Protocol Summary and Interim Report
Year: 2005
Type: article
Source: Clinical Lymphoma
Authors: Sattva S. Neelapu, Barry L. Gause, Daniel A. Nikcevich, Stephen J. Schuster, Jane Winter, Jon P. Gockerman, Thomas Loughran, Ken Takeshita, Giorgio Inghirami, Dean McGaughey, Thelma M. Watson, Sandra Snow, Paula Kubovic, Miriam Ferraro, Elizabeth Jones, Elaine S. Jaffe, Douglas J. Schwartzentruber, David Danforth, Richard Sherry, Erik Kass, Carter Van Waes, Craig W. Reynolds, Larry W. Kwak
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Duluth Clinic, University of Pennsylvania, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Duke University, University of South Florida, Moffitt Cancer Center, New York University, Virginia Oncology Associates, National Institute on Deafness and Other Communication Disorders
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2130416849